These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19286357)

  • 1. Implications of regular solution theory on the release mechanism of catanionic mixtures from gels.
    Bramer T; Frenning G; Gråsjö J; Edsman K; Hansson P
    Colloids Surf B Biointerfaces; 2009 Jul; 71(2):214-25. PubMed ID: 19286357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catanionic aggregates formed from drugs and lauric or capric acids enable prolonged release from gels.
    Dew N; Bramer T; Edsman K
    J Colloid Interface Sci; 2008 Jul; 323(2):386-94. PubMed ID: 18479696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catanionic mixtures involving a drug: a rather general concept that can be utilized for prolonged drug release from gels.
    Bramer T; Dew N; Edsman K
    J Pharm Sci; 2006 Apr; 95(4):769-80. PubMed ID: 16498573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catanionic drug-surfactant mixtures: phase behavior and sustained release from gels.
    Bramer T; Paulsson M; Edwards K; Edsman K
    Pharm Res; 2003 Oct; 20(10):1661-7. PubMed ID: 14620523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gel formation in systems composed of drug containing catanionic vesicles and oppositely charged hydrophobically modified polymer.
    Dew N; Edwards K; Edsman K
    Colloids Surf B Biointerfaces; 2009 May; 70(2):187-97. PubMed ID: 19167869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gel formulations containing catanionic vesicles composed of alprenolol and SDS: effects of drug release and skin penetration on aggregate structure.
    Dew N; Edwards K; Eriksson J; Edsman K; Björk E
    Colloids Surf B Biointerfaces; 2012 Jan; 89():53-60. PubMed ID: 21958537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel gel formulations with catanionic aggregates enable prolonged drug release and reduced skin permeation.
    Dew N; Edsman K; Björk E
    J Pharm Pharmacol; 2011 Oct; 63(10):1265-73. PubMed ID: 21899541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical applications for catanionic mixtures.
    Bramer T; Dew N; Edsman K
    J Pharm Pharmacol; 2007 Oct; 59(10):1319-34. PubMed ID: 17910806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effects in mixtures of oppositely charged surfactants as calculated from the Poisson-Boltzmann theory: a comparison between theoretical predictions and experiments.
    Bergström LM; Bramer T
    J Colloid Interface Sci; 2008 Jun; 322(2):589-95. PubMed ID: 18387619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of drug/surfactant catanionic vesicles and their application in sustained drug release.
    Jiang Y; Li F; Luan Y; Cao W; Ji X; Zhao L; Zhang L; Li Z
    Int J Pharm; 2012 Oct; 436(1-2):806-14. PubMed ID: 22871561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ionic surfactants on drainage and equilibrium thickness of emulsion films.
    Karakashev SI; Manev ED; Tsekov R; Nguyen AV
    J Colloid Interface Sci; 2008 Feb; 318(2):358-64. PubMed ID: 18036602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrodynamic investigations of ion transport and structural properties in drug-containing gels: dielectric spectroscopy and transient current measurements on catanionic carbopol systems.
    Brohede U; Bramer T; Edsman K; Strømme M
    J Phys Chem B; 2005 Aug; 109(32):15250-5. PubMed ID: 16852931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diffusion behaviors of drugs in thermosensitive in situ gels].
    Wei G; Lu WY; Zheng JM
    Yao Xue Xue Bao; 2004 Mar; 39(3):232-5. PubMed ID: 15171663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release characteristics of anionic drug compounds from liquid crystalline gels. Part II. The effects of ion pairing and buffering on the passive delivery of anionic drugs across non-rate-limiting membranes.
    Fitzpatrick D; Corish J
    Int J Pharm; 2006 Mar; 311(1-2):139-46. PubMed ID: 16426777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of original bioactive formulations based on sugar-surfactant/non-steroidal anti-inflammatory catanionic self-assemblies: a new way of dermal drug delivery.
    Consola S; Blanzat M; Perez E; Garrigues JC; Bordat P; Rico-Lattes I
    Chemistry; 2007; 13(11):3039-47. PubMed ID: 17285653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-assembly of regular hollow icosahedra in salt-free catanionic solutions.
    Dubois M; Demé B; Gulik-Krzywicki T; Dedieu JC; Vautrin C; Désert S; Perez E; Zemb T
    Nature; 2001 Jun; 411(6838):672-5. PubMed ID: 11395764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural properties of ionic detergent aggregates: a large-scale molecular dynamics study of sodium dodecyl sulfate.
    Sammalkorpi M; Karttunen M; Haataja M
    J Phys Chem B; 2007 Oct; 111(40):11722-33. PubMed ID: 17877384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights on polymer surfactant complex structures during the binding of surfactants to polymers as measured by equilibrium and structural techniques.
    Tam KC; Wyn-Jones E
    Chem Soc Rev; 2006 Aug; 35(8):693-709. PubMed ID: 16862270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release characteristics of anionic drug compounds from liquid crystalline gels III. Chemical and iontophoretic enhancement of delivery across non-rate-limiting membranes.
    Fitzpatrick D; Corish J
    Int J Pharm; 2006 Nov; 325(1-2):90-8. PubMed ID: 16963208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Strategies in the Development of Catanionic Vesicles.
    Kuo AT; Chang CH
    J Oleo Sci; 2016 May; 65(5):377-84. PubMed ID: 27086996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.